Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
InChi: InChI=1S/C21H17NO3/c1-13-3-2-4-18-19(13)22-20(25)21(18
SRPK1 is a common binding partner of the E1^E4 protein of diverse human papillomavirus types
Epub 2006 Aug 4
is formed primarily from the breakdown of ceramide
PubMed PMID: 19519883
Tipranavir Catalog No.:M10307-2 InChi: InChI=1S/C21H17NO3/c1-13-3-2-4-18-19(13)22-20(25)21(18Tipranavir is a nonpeptidic protease inhibitor. Tipranavir has the ability to inhibit the replication of viruses that are resistant to other protease inhibitors and it recommended for patients who are resistant to other treatments. Resistance to tipranavir itself seems to require multiple mutations. Tipranavir was approved by the Food and Drug Administration (FDA) on June 22, 2005, and was approved for pediatric use on June 24, 2008. Like lopinavir
US$ 38.00
US$ 38.00
US$ 38.00
US$ 38.00
US$ 68.00
US$ 38.00